| WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I) (NCT07615894) | WestVac Biopharma Co., Ltd. | 2026-06-01 |
| A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer. (NCT07462468) | WestVac Biopharma Co., Ltd. | 2026-03-10 |
| A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets (NCT07170800) | WestVac Biopharma Co., Ltd. | 2025-09-19 |
| A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination (NCT05911048) | WestVac Biopharma Co., Ltd. | 2024-12-30 |
| A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination (NCT05911061) | WestVac Biopharma Co., Ltd. | 2024-12-30 |
| Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents (NCT05013983) | WestVac Biopharma Co., Ltd. | 2024-07-01 |
| A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell) (NCT06175494) | WestVac Biopharma Co., Ltd. | 2023-12-19 |
| Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster (NCT05465902) | WestVac Biopharma Co., Ltd. | 2023-07-07 |
| Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (NCT05770180) | WestVac Biopharma Co., Ltd. | 2023-03-30 |
| Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102) (NCT05765604) | WestVac Biopharma Co., Ltd. | 2023-03-14 |
| A Clinical Study to Evaluate the Safety and Immunogenicity of the Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster (NCT06381843) | WestVac Biopharma Co., Ltd. | 2022-08-02 |
| A Clinical Trial of Immuno-bridging Between Different Manufacture Scales of Recombinant COVID-19 Vaccine (Sf9 Cell) (NCT05465785) | WestVac Biopharma Co., Ltd. | 2022-07-20 |
| Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster (NCT05463354) | WestVac Biopharma Co., Ltd. | 2022-07-11 |